News
Apr. 12, 2010:
MaRS Innovation to assist with business development and marketing
Mount Sinai Hospital has entered an Agency Agreement with MaRS Innovation, who will assist in commercialization, marketing and business development for the Dynemo methodology.
About MaRS Innovation
MaRS Innovation (www.marsinnovation.com) provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 14 leading Toronto academic institutions. MaRS Innovation is a non-profit organization with an independent industry-led Board of Directors, funded through the Government of Canada's Networks of Centres of Excellence and contributions of its member institutions.
Jan. 28, 2009:
New technology discovered at Mount Sinai Hospital holds promise for improved breast cancer treatment
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient’s best treatment options. The tool can predict with more than 80 per cent accuracy a patient’s chance of recovering from breast cancer.
Click here to download the PDF
MaRS Innovation to assist with business development and marketing
Mount Sinai Hospital has entered an Agency Agreement with MaRS Innovation, who will assist in commercialization, marketing and business development for the Dynemo methodology.
About MaRS Innovation
MaRS Innovation (www.marsinnovation.com) provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 14 leading Toronto academic institutions. MaRS Innovation is a non-profit organization with an independent industry-led Board of Directors, funded through the Government of Canada's Networks of Centres of Excellence and contributions of its member institutions.
Jan. 28, 2009:
New technology discovered at Mount Sinai Hospital holds promise for improved breast cancer treatment
In a study published by Nature Biotechnology online on February 1, 2009, Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient’s best treatment options. The tool can predict with more than 80 per cent accuracy a patient’s chance of recovering from breast cancer.
Click here to download the PDF
Events
Jun. 22, 2010:
Dx2010 Markers to Markets
Click here to visit the event website
Jun. 4 - 8, 2010:
2010 ASCO Annual Meeting, Chicago
Click here to visit the event website
May 3 - 6, 2010:
BIO International Convention, Chicago
Click here to visit the event website
Apr. 13 - 14, 2010:
Alliance Management Congress, Philadelphia
Click here to visit the event website
Jun. 15 - 16, 2009:
qPCR and Transcriptional Profiling Conference
Click here to visit the event website
Dx2010 Markers to Markets
Click here to visit the event website
Jun. 4 - 8, 2010:
2010 ASCO Annual Meeting, Chicago
Click here to visit the event website
May 3 - 6, 2010:
BIO International Convention, Chicago
Click here to visit the event website
Apr. 13 - 14, 2010:
Alliance Management Congress, Philadelphia
Click here to visit the event website
Jun. 15 - 16, 2009:
qPCR and Transcriptional Profiling Conference
Click here to visit the event website